Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Biennial CEM in Women With a Personal History of Breast Cancer

NCT: NCT06105749 · RECRUITING

NCT IDNCT06105749
StatusRECRUITING
Start Date2023-11-08
Completion2031-04
SponsorWendie Berg (OTHER)
First posted
Last updated

Brief Summary

This is a prospective clinical trial that will examine if biennial contrast-enhanced mammography added to annual 3D mammography (tomosynthesis) substantially improves breast cancer detection with minimal increase in false-positives, in women with a personal history of breast cancer.

Frequently Asked Questions

What is Biennial CEM in Women With a Personal History of Breast Cancer?

Biennial CEM in Women With a Personal History of Breast Cancer is a clinical trial registered under NCT06105749. Current status: RECRUITING.

What is the status of NCT06105749?

The current status of NCT06105749 (Biennial CEM in Women With a Personal History of Breast Cancer) is: RECRUITING.

When did Biennial CEM in Women With a Personal History of Breast Cancer start?

Biennial CEM in Women With a Personal History of Breast Cancer started on 2023-11-08.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.